#Sweden #Stockholm #CEO #Medicover #John Stubbington

Leadership Transition at Medicover

In a significant corporate shift, Medicover AB has announced the appointment of John Stubbington as the new CEO, effective from May 1, 2025. This transition comes as the current CEO, Fredrik Rågmark, prepares to step down after an impressive 30-year career with the company, including 25 years at the helm as CEO. Rågmark has played a crucial role in cultivating Medicover into a leading provider of healthcare and diagnostic services during his tenure.

Fredrik Stenmo, the Chairman of the Board, expressed deep gratitude for Rågmark's exceptional contributions and leadership over the years. "Fredrik has been instrumental in Medicover’s success and in establishing our reputation as a premier healthcare provider," stated Stenmo.

Before assuming his new role, Stubbington will be transitioning from his position as the Chief Operating Officer (COO) of Medicover’s Healthcare Services division. Stubbington has been with Medicover since 2010, bringing valuable experiences from his previous role at BUPA, a prominent global health insurer, where he spent nine years in their International division.

In a statement, Stubbington expressed gratitude for the board's trust in him and looked forward to building upon the strong foundation laid by Rågmark and the leadership team. He stated, "I am honored to keep advancing the platform built over many years and aim to continue Medicover's journey toward success with our dedicated team."

Rågmark concluded that stepping down is the right decision for both himself and the company, emphasizing his pride in the growth of Medicover and the company's persistent drive for organic growth that has characterized his leadership.

Founded in 1995, Medicover has established a vast network of ambulatory clinics, hospitals, and laboratories across countries, notably in Poland, Germany, Romania, and India. As of 2023, the company reported revenue of €1,746 million and employed over 45,000 individuals across its operations.

The transition of leadership marks a new chapter in Medicover’s journey as it aims to maintain its leading position in the healthcare industry. With Stubbington’s extensive background and commitment, the company is well-positioned for sustained growth and innovation in its services.

In summary, as Medicover prepares for a new leadership era, the healthcare community watches closely to see how John Stubbington will navigate the challenges ahead and build upon the legacy of his predecessor, Fredrik Rågmark. For further updates on this transition, interested parties are encouraged to stay tuned for future announcements from Medicover.

For Additional Information

For more details, please reach out to:
Hanna Bjellquist
Head of Investor Relations
Phone: +46 703 033 272
Email: [email protected]
Fredrik Stenmo
Chairman of the Board
Email: [email protected]

Whether you’re an investor, employee, or simply interested in healthcare advancements, the upcoming changes at Medicover present an exciting opportunity to observe how new leadership influences the organization’s direction and strategies.